| 注册
首页|期刊导航|中国药房|氟伏沙明对比氯米帕明治疗强迫症的疗效与安全性的Meta分析

氟伏沙明对比氯米帕明治疗强迫症的疗效与安全性的Meta分析

何敏 白菁 王艳涛 杨荣梅

中国药房2013,Vol.24Issue(28):2620-2623,4.
中国药房2013,Vol.24Issue(28):2620-2623,4.DOI:10.6039/j.issn.1001-0408.2013.28.10

氟伏沙明对比氯米帕明治疗强迫症的疗效与安全性的Meta分析

Meta-analysis of Efficacy and Safety of Fluvoxamine and Clomipramine in the Treatment of Obsessive-compulsive Disorder

何敏 1白菁 2王艳涛 1杨荣梅1

作者信息

  • 1. 杭州市第七人民医院,杭州310013
  • 2. 空军杭州航空医学鉴定训练中心,杭州310007
  • 折叠

摘要

Abstract

OBJECTIVE:To compare the efficacy and safety of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.METHODS:Retrieved from CNKI,Wanfang database,VIP database,domestic published RCT about fluvoxamine vs.clomipramine in the treatment of obsessive-compulsive disorder were collected,and the methodology of included studies was evaluated.Rev Man 4.2 statistical software was used for Meta-analysis.RESULTS:A total of 11 RCT were included,involving 625 patients.Meta-analysis showed that the total effective rate [OR=1.12,95%CI(0.88,1.55),P=0.51] and cure rate [OR=1.20,95% CI (0.80,1.80),P=0.38] of fluvoxamine were not statistically significant different from those of clomipramine;the incidence of ADR in fluvoxamine group was significantly lower than in clomipramine group,there was statistical significance (P<0.05).CONCLUSIONS:Efficacy of fluvoxamine is similar to clomipramine in the treatment of obsessive-compulsive disorder,but shows better safety.

关键词

氟伏沙明/氯米帕明/强迫症/Meta分析

Key words

Fluvoxamine/ Clomipramine/ Obsessive-compulsive disorder/ Meta-analysis

分类

医药卫生

引用本文复制引用

何敏,白菁,王艳涛,杨荣梅..氟伏沙明对比氯米帕明治疗强迫症的疗效与安全性的Meta分析[J].中国药房,2013,24(28):2620-2623,4.

基金项目

空军后勤部卫生部科研课题(No.BKJ10R019) (No.BKJ10R019)

中国药房

OACSCDCSTPCD

1001-0408

访问量4
|
下载量0
段落导航相关论文